Oct 2025 Articles

Articles
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis
Nicholls SJ, Nelson AJ, Ray KK, et al.
Journal:
J Am Coll Cardiol

First published: October 7, 2025 DOI: 10.1016/j.jacc.2025.07.056
View
- Share
Articles
South Asian Representation in Cardiovascular Disease Randomized Controlled Trials: A Systematic Review
Uppal N, Patel AP, Bhatt DL, et al.
Journal:
JACC Asia

First published: October 5, 2025 DOI: 10.1016/j.jacasi.2025.06.017
View
- Share
Articles
Great debate: fire-and-forget beats personalized lipid-lowering treatment
Tokgozoglu, L
Journal:
Eur Heart J

First published: October 3, 2025 DOI: 10.1093/eurheartj/ehaf567
View
- Share
Articles
Factors Associated with Elevated High-Sensitivity C-Reactive Protein Levels in Individuals with Atherosclerotic Cardiovascular Disease in the US and the UK
Ray KK, Reuter SB, Dalbeler A, et al.
Journal:
Eur J Prev Cardiol

First published: October 1, 2025 DOI: 10.1093/eurjpc/zwaf609
View
- Share